- Home
- GERN vs ULH Comparison
GERN vs ULH Comparison
Compare GERN & ULH Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- GERN
- ULH
- Stock Information
- Founded
- GERN 1990
- ULH 1932
- Country
- GERN United States
- ULH United States
- Employees
- GERN N/A
- ULH N/A
- Industry
- GERN Biotechnology: Pharmaceutical Preparations
- ULH Trucking Freight/Courier Services
- Sector
- GERN Health Care
- ULH Industrials
- Exchange
- GERN Nasdaq
- ULH Nasdaq
- Market Cap
- GERN 840.7M
- ULH 591.6M
- IPO Year
- GERN 1996
- ULH 2005
- Fundamental
- Price
- GERN $1.18
- ULH $23.31
- Analyst Decision
- GERN Buy
- ULH Hold
- Analyst Count
- GERN 9
- ULH 1
- Target Price
- GERN $5.13
- ULH $29.00
- AVG Volume (30 Days)
- GERN 11.5M
- ULH 72.6K
- Earning Date
- GERN 05-07-2025
- ULH 04-24-2025
- Dividend Yield
- GERN N/A
- ULH 1.80%
- EPS Growth
- GERN N/A
- ULH N/A
- EPS
- GERN N/A
- ULH 3.17
- Revenue
- GERN $116,293,000.00
- ULH $1,736,518,000.00
- Revenue This Year
- GERN $194.54
- ULH N/A
- Revenue Next Year
- GERN $56.51
- ULH $7.92
- P/E Ratio
- GERN N/A
- ULH $7.35
- Revenue Growth
- GERN 22264.04
- ULH 1.16
- 52 Week Low
- GERN $1.17
- ULH $20.60
- 52 Week High
- GERN $5.34
- ULH $53.29
- Technical
- Relative Strength Index (RSI)
- GERN 32.46
- ULH 43.32
- Support Level
- GERN $1.34
- ULH $21.65
- Resistance Level
- GERN $1.44
- ULH $23.48
- Average True Range (ATR)
- GERN 0.10
- ULH 1.37
- MACD
- GERN 0.00
- ULH -0.01
- Stochastic Oscillator
- GERN 3.23
- ULH 36.75
About GERN Geron Corporation
Geron Corp is a clinical-stage biopharmaceutical company focused on the research and development of cancer treatments. The company's drug in development, Imelstat, is being tested for the treatment of myelodysplastic syndromes, which are disorders of the blood, and myelofibrosis, which is a rare blood cancer affecting bone marrow. The company earns revenue through collaboration agreements, milestones, royalties, and licensing arrangements. Geron possesses various rights to this drug. The company operates as a single segment being, the development of therapeutic products for oncology.
About ULH Universal Logistics Holdings Inc.
Universal Logistics Holdings Inc is an asset-light provider of customized transportation and logistics solutions throughout the United States, and in Mexico, Canada and Colombia. It offers services such as truckload, brokerage, intermodal, dedicated, and value-added services. The company reports into four segments namely trucking, intermodal, company-managed brokerage, and contract logistics. The majority of the revenue is earned from the contract logistics segment.